Jefferies Reiterates Buy Rating on Viking Therapeutic (VKTX): "VKTX is in an execution mode this year"

March 12, 2026 12:48 PM

Jefferies analyst Roger Song reiterated a Buy rating and $101.00 price target on Viking Therapeutic (NASDAQ: VKTX)The analyst commented, "We ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found